FemPulse得到FDA的批准,可以测试一种新的阴道装置,以检测女性的过活膀胱。 FemPulse gets FDA approval to test a new vaginal device for overactive bladder in women.

FemPulse已获得林业发展局批准,开始对其新装置进行临床试验,该装置旨在治疗妇女过度活性膀胱。 FemPulse has received FDA approval to begin a clinical trial for its new device designed to treat overactive bladder in women. 插入阴道的可穿戴装置旨在提供持续的神经刺激,替代药物。 The wearable device, inserted vaginally, aims to provide continuous nerve stimulation as an alternative to medication. 如果成功, 它可能为数百万患有OAB的妇女提供一种新的治疗选择. If successful, it could offer a new treatment option for millions of women suffering from OAB. 该公司还正在欧洲寻求对该装置的监管批准。 The company is also seeking regulatory approval in Europe for the device.